Growth factors as therapeutic targets in HCCFURUSE, Junji.Critical reviews in oncology/hematology. 2008, Vol 67, Num 1, pp 8-15, issn 1040-8428, 8 p.Article

Impact of gemcitabine on the treatment of metastatic pancreatic cancerISHII, Hiroshi; FURUSE, Junji; NAGASE, Michitaka et al.Journal of gastroenterology and hepatology. 2005, Vol 20, Num 1, pp 62-66, issn 0815-9319, 5 p.Article

Evaluation of contrast Enhancement patterns in pancreatic tumors by coded harmonic sonographic imaging with a microbubble contrast agentNAGASE, Michitaka; FURUSE, Junji; ISHII, Hiroshi et al.Journal of ultrasound in medicine. 2003, Vol 22, Num 8, pp 789-795, issn 0278-4297, 7 p.Article

Intrahepatic pseudoaneurysm: a complication following radio-frequency ablation therapy for hepatocellular carcinomaTAMAI, Fumihiro; FURUSE, Junji; MARU, Yasushi et al.European journal of radiology. 2002, Vol 44, Num 1, pp 40-43, issn 0720-048XArticle

Autofluorescence endoscopy images of pancreas cancer: Report of a caseIZUISHI, Kunihiko; FURUSE, Junji; KINOSHITA, Taira et al.Hepato-gastroenterology. 2003, Vol 50, Num 50, pp 366-367, issn 0172-6390, 2 p.Article

A late phase II study of S-1 for metastatic pancreatic cancerOKUSAKA, Takuji; FUNAKOSHI, Akihiro; FURUSE, Junji et al.Cancer chemotherapy and pharmacology. 2008, Vol 61, Num 4, pp 615-621, issn 0344-5704, 7 p.Article

Combination radiotherapy for hepatocellular carcinoma with intraductal tumor thrombus: A case reportTANIZAKI, Hiroshi; FURUSE, Junji; YOSHINO, Masahiro et al.European journal of radiology. 2001, Vol 38, Num 3, pp 213-218, issn 0720-048XArticle

Chemotherapy in the treatment of advanced gallbladder cancerISHII, Hiroshi; FURUSE, Junji; YONEMOTO, Naohiro et al.Oncology. 2004, Vol 66, Num 2, pp 138-142, issn 0030-2414, 5 p.Article

Adverse hepatic events caused by radiotherapy for advanced hepatocellular carcinomaFURUSE, Junji; ISHII, Hiroshi; NAGASE, Michitaka et al.Journal of gastroenterology and hepatology. 2005, Vol 20, Num 10, pp 1512-1518, issn 0815-9319, 7 p.Article

Clinical characteristics of hepatocellular carcinoma with an extensive lymph node metastasis at diagnosisABE, Tatsuya; FURUSE, Junji; YOSHINO, Masahiro et al.American journal of clinical oncology. 2002, Vol 25, Num 3, pp 318-323, issn 0277-3732Article

Lessons from the comparison of two randomized clinical trials using gemcitabine and cisplatin for advanced biliary tract cancerFURUSE, Junji; OKUSAKA, Takuji; BRIDGEWATER, John et al.Critical reviews in oncology/hematology. 2011, Vol 80, Num 1, pp 31-39, issn 1040-8428, 9 p.Article

Phase I study of sorafenib in Japanese patients with hepatocellular carcinomaFURUSE, Junji; ISHII, Hiroshi; NAKACHI, Kohei et al.Cancer science. 2008, Vol 99, Num 1, pp 159-165, issn 1347-9032, 7 p.Article

S-1 monotherapy as first-line treatment in patients with advanced biliary tract cancer : a multicenter phase II studyFURUSE, Junji; OKUSAKA, Takuji; BOKU, Narikazu et al.Cancer chemotherapy and pharmacology. 2008, Vol 62, Num 5, pp 849-855, issn 0344-5704, 7 p.Article

Relief of jaundice by external beam radiotherapy and intraluminal brachytherapy in patients with extrahepatic cholangiocarcinoma: Results without stentingISHII, Hiroshi; FURUSE, Junji; NAGASE, Michitaka et al.Hepato-gastroenterology. 2004, Vol 51, Num 58, pp 954-957, issn 0172-6390, 4 p.Article

Radiofrequency ablation for hepatocellular carcinoma induces glypican-3 peptide-specific cytotoxic T lymphocytesNOBLJOKA, Daisuke; MOTOMURA, Yutaka; TAKAHASHI, Shinichiro et al.International journal of oncology. 2012, Vol 40, Num 1, pp 63-70, issn 1019-6439, 8 p.Article

Phase II study of erlotinib plus gemcitabine in Japanese patients with unresectable pancreatic cancerOKUSAKA, Takuji; FURUSE, Junji; ITO, Tetsuhide et al.Cancer science. 2011, Vol 102, Num 2, pp 425-431, issn 1347-9032, 7 p.Article

A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancerFURUSE, Junji; OKUSAKA, Takuji; OHKAWA, Shinichi et al.Cancer chemotherapy and pharmacology. 2010, Vol 65, Num 1, pp 113-120, issn 0344-5704, 8 p.Article

Population Pharmacokinetics of Gemcitabine and Its Metabolite in Japanese Cancer Patients: Impact of Genetic PolymorphismsSUGIYAMA, Emiko; KANIWA, Nahoko; YAMAMOTO, Noboru et al.Clinical pharmacokinetics. 2010, Vol 49, Num 8, pp 549-558, issn 0312-5963, 10 p.Article

Severe drug toxicity associated with a single-nucleotide polymorphism of the Cytidine deaminase gene in a Japanese cancer patient treated with gemcitabine plus cisplatinYONEMORI, Kan; UENO, Hideki; KIM, Su-Ryang et al.Clinical cancer research. 2005, Vol 11, Num 7, pp 2620-2624, issn 1078-0432, 5 p.Article

A phase I study of combination chemotherapy with gemcitabine and oral S-1 for advanced pancreatic cancerUENO, Hideki; OKUSAKA, Takuji; IKEDA, Masafumi et al.Oncology. 2005, Vol 69, Num 5, pp 421-427, issn 0030-2414, 7 p.Article

Hepatic arterial infusion of 5-fluorouracil for liver metastases from pancreatic carcinoma : Results from a pilot studyFURUSE, Junji; MARU, Yasushi; KAWASHIMA, Mitsuhiko et al.Hepato-gastroenterology. 2001, Vol 48, Num 37, pp 208-211, issn 0172-6390Article

Effect of Everolimus on Survival in Advanced Hepatocellular Carcinoma After Failure of Sorafenib: The EVOLVE-1 Randomized Clinical TrialZHU, Andrew X; KUDO, Masatoshi; DORVAL, Etienne et al.JAMA, the journal of the American Medical Association. 2014, Vol 312, Num 1, pp 57-67, issn 0098-7484, 11 p.Article

Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinomaKUDO, Masatoshi; IMANAKA, Kazuho; KANEKO, Shuichi et al.European journal of cancer (1990). 2011, Vol 47, Num 14, pp 2117-2127, issn 0959-8049, 11 p.Article

Intraoperative and conformal external-beam radiation therapy with protracted 5-fluorouracil infusion in patients with locally advanced pancreatic carcinomaFURUSE, Junji; KINOSHITA, Taira; MARU, Yasushi et al.Cancer. 2003, Vol 97, Num 5, pp 1346-1352, issn 0008-543X, 7 p.Article

Pilot study of transcatheter arterial chemoembolization with degradable starch microspheres in patients with hepatocellular carcinomaFURUSE, Junji; ISHII, Hiroshi; SATAKE, Mitsuo et al.American journal of clinical oncology. 2003, Vol 26, Num 2, pp 159-164, issn 0277-3732, 6 p.Article